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Abstract
Background:  Shunt infection in hydrocephalus patients is a severe, even life-threatening
complication. Antibiotic-impregnated shunts (AIS) have been developed in an attempt to reduce
rate of shunt infection. The study was performed to analyze if AIS can diminish the rate of shunt
infection. The pathogenic nature of shunt infection in patients with AIS systems and those without
antibiotic impregnated shunts (non-AIS) was compared.
Methods: Over a period of 24 months in the Department of Neurosurgery at University Hospital
of Tübingen shunt surgery was performed in 258 patients. In 86 patients AIS systems were
implanted. Shunt catheters were commercially impregnated with clindamycin and rifampicin.
Analysis of the clinical data included sex, age, classification of hydrocephalus, shunt types and risk
factors for shunt infection [age (< 1 year and > 80 years), prematurely born patients, external
ventricular drainage, former shunt infection, former systemic infection, disturbance of
consciousness, former radiation-/chemotherapy]. Infection rates and underlying bacterial
pathogens of patients with AIS were compared to patients with implanted non-AIS systems (172
patients).
Results: AIS and non-AIS patients did not differ in sex, etiology of hydrocephalus and the shunt
type. In the AIS group 72 out of 86 patients had at least one risk factor (83.7 %), compared to 126
patients in the non-AIS group (73.3 %). There was no significant difference between the two groups
(p = 0.0629; Fisher's exact test). In patients with no risk factors, only one patient with non-AIS
suffered from shunt infection. In patients with one or more risk factors the rate for shunt infection
was 7.14 % in patients with non-AIS and 6.94 % in patients with AIS. Former shunt infection (p =
0.0124) was related to higher risk for shunt infection. The use of AIS had therefore no significant
advantage (p = 0.8611; multiple logistic regression).
Significantly related to a shunt infection was the number of shunt surgeries. 190 interventions in
the AIS group (2.21 interventions per patient) and 408 in the non-AIS group (2.37 interventions
per patient) had been performed (p = 0.3063; Wilcoxon). There was no shunt infection in the
group of patients on whom only one shunt surgery was performed. In patients with at least two
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shunt surgeries the infection rate was 9%. The infection rate in AIS patients was 5/52 (9.6 %) and
in the non-AIS 10/114 (8.77 %), (p = 1.0; Fisher's exact test). Staphylococcus epidermidis was the
most frequent pathogen for shunt infection. Fourteen out of 15 infections occurred within the first
6 months of surgery. The most frequent pathogen for shunt infection was S. epidermidis. No toxic
or allergic complications were seen using the AIS shunt systems. The presented data show a
remarkably low infection rate of 5.8 % in the non-AIS group compared to other studies which
demonstrated a significant decrease in the infection rate by AIS.
Conclusion: AIS did not significantly reduce shunt infection in hydrocephalus patients in the
presented study. In the AIS group three patients suffered from shunt infections caused by skin
ulceration or neurosurgical procedures with exposure of the cerebrospinal liquor after shunt
implantation. AIS was not developed to prevent infection in such cases, therefore an advantage of
AIS can not be excluded. In view of the presented data and the small number of reported studies
a prospective randomized multicenter study is required.
Background
Shunt infection is a serious complication causing persist-
ing intellectual, cognitive and neurological deficits [1]. It
may be even a life threatening complication. In addition
to this, severe individual impairment cost of complication
management sums up to 27,000 to 30,000 $ per patient
[2].
The rate of shunt infection varies from 0.3 to 12.9 % [2-
9]. Risk factors for shunt infection include surgeon's expe-
rience, duration of surgery, and intraoperative handling of
the device. Further unfavorable conditions for shunt oper-
ations are late timing of surgery and overcrowded operat-
ing theatres [10,11]. These factors can be influenced by
rigorous planning and improved organisation [12].
Already in 1992, Choux et al. [13] established rules for the
operating theatre to reduce shunt infection by influencing
these risk factors. They were able to reduce their infection
rate in 600 children to 0.33 % by strictly complying with
the so-called „Choux's rules“. In 2005, Choksey and Malik
reported only one shunt infection in a total of 176 shunt
procedures performed in 126 patients with hydrocepha-
lus due to strictly adhering to the following surgical prin-
ciples: asepsis, antisepsis, antimicrobial therapy, and the
avoidance of haematomas [11]. In contrast, several risk
factors causing shunt infection cannot be influenced:
patients' age, suppressed immune system e.g. in patients
receiving radiation and/or chemotherapy, in long-term
intensive care, with a disturbed level of consciousness,
skin alterations, previous infection and external cerebros-
pinal fluid drainage previous to shunt implantation.
A promising alternative is to use antibiotic-impregnated
shunts (AIS) in order to reduce the rate of shunt infec-
tions.
The aim of the present study was to investigate whether
AIS can diminish the rate of shunt infections. Risk factors
for shunt infection were analysed. Furthermore, a compar-
ison was made between the pathogenic nature of a shunt
infection in patients with AIS systems and those without
AIS (non-AIS).
Methods
Patients
Over a two-year period, 258 patients underwent shunt
surgery in the Department of Neurosurgery at the Univer-
sity of Tübingen, Germany. Shunt insertions were per-
formed by variably experienced surgeons (consultants
and residents). The decision whether to implant an AIS or
non-AIS system was made by the responsible surgeon.
Shunt-catheters impregnated with clindamycin and
rifampicin (Bactiseal, Codman, Johnson & Johnson, Bos-
ton, USA) were available for all patients.
Operative technique
With induction of general anesthesia, a single shot of 3
gram cefuroxim was given to adults intravenously. Chil-
dren received 100 mg per kg body weight. Scalp hair was
shaved widely before the skin was prepared with benzine.
After marking skin incisions, the head, trunk and abdo-
men were prepared with alcoholic disinfection. The pinna
of the ear was carefully taped forward. The operative area
was draped, using sterile adhesive drapes, followed by a
second layer of towels to cover the entire operating theatre
table down to the floor level. The operative field was
sealed by transparent sterile adhesive foil. Initially, the
distal end of the abdominal catheter was implanted intra-
peritoneally through a transverse right incision paramedi-
ally to the umbilicus. The catheter was then tunneled up
to the retroauricular area. A skin incision was performed 3
cm behind the ear to insert a programmable shunt
(Hakim Programmable Valve Shunt, Codman, Johnson &
Johnson, Boston, USA) with a tunneller. The final step
was the insertion of the ventricular catheter. A parame-
dian right precoronary frontal burr hole was used when-
ever possible followed by opening the dura and
diathermizing the arachnoid for the implantation of theBMC Infectious Diseases 2007, 7:38 http://www.biomedcentral.com/1471-2334/7/38
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ventricular catheter. The wounds were closed using 3-0
atraumatic sutures, then disinfected using betaisodona
solution and finally covered with sterile adhesive plaster.
Definition of shunt infection
Shunt infection was defined when cerebrospinal fluid or
the shunt tip was contaminated with bacteria and the
patient showed clinical signs of acute bacterial meningitis
and symptoms of shunt malfunction or obstruction.
Additionally, one of the following parameters of bacterial
inflammation of the cerebrospinal fluid (CSF) had to be
positive: (i) leukocyte count of >0.25 × 109/L with pre-
dominantly poly-morphonuclear cells, (ii) a CSF lactate
concentration of >3.5 mmol/L, (iii) a glucose ratio (CSF
glucose/serum glucose) of <0.4, (iv) a CSF glucose value
of <2.5 mmol/L when no simultaneous value was noted
in the blood glucose [14,15]. The antibiograms were spec-
ified by agar diffusion test according to the standards of
NCCLS [16], alternatively the pathogens were tested by
Vitek 2 [17].
Ethical aspects
This study was approved by the ethical committee of the
faculty of medicine of the Eberhard-Karls-Universität
Tübingen.
Statistical analysis
Dichotomous data were compared with Fisher's exact test.
Continuous data were compared with the two-sample t-
test. A Wilcoxon test was used to compare the two treat-
ment groups with respect to the number of surgeries.
Nominal data (classification of hydrocephalus) were
compared by contingency table analysis. Multiple logistic
regressions were used to investigate the influence of nom-
inal factors together with the influence of treatment on
the risk of a shunt infection. We first used a full model,
which includes the interaction term. Since this turned out
to be nonsignificant for all risk factors, the model was
simplified to contain only the two main factors. For each
test we calculated the corresponding p-value. All statistical
methods were carried out with the statistical software
package, JMP version 6.0.3 [18].
For determining the sample size required in a prospective
study the software PS: Power and Sample Size Calcula-
tion, version 2.1.30 was used [19].
Results
In 258 patients shunt procedures were performed in the
Department of Neurosurgery, University of Tübingen,
over a period of 24 months. AIS were used (Codman Bac-
tiseal, Antimicrobial Impregnated catheter system) in 86
patients. The shunts were impregnated with clindamycin
and rifampicin. Non-AIS were used in 172 patients.
Table 1 shows details comparing the two groups with
respect to their age, sex, etiology of hydrocephalus, and
the shunt type. The comparison of the AIS and non-AIS
group showed no difference between the two groups in
sex, etiology of hydrocephalus and the shunt type. The AIS
group was about ten years younger than the non-AIS
group. This is due to the fact that there were nearly twice
as many children less than ten years in the AIS group com-
pared to the non-AIS group. In Table 2, factors assumed to
influence the risk for shunt infection are listed. In the AIS
group, 72 out of 86 patients had at least one risk factor
(83.7 %). In the non-AIS group 126 patients had at least
one risk factor (73.3 %), i.e. we could not detect a signifi-
cant difference between the two groups (p = 0.0629;
Fisher's exact test). The risk of shunt infection by age is
characterized in more detail in Table 3. Patients initially
assumed for higher risk had an infection rate of 3 % com-
pared to patients assumed for normal risk. Former shunt
infection resulted in 18.5 % a shunt infection, whereas
only 4.3 % with no former shunt infection suffered from
a shunt infection (p = 0.0124 Fisher's exact test; OR 5.0;
95% CI 1.6 – 16.0) (Table 4).
The rates of shunt infections related to the risk factors and
the kind of treatment (AIS vs non-AIS) are summarized in
Table 5. In patients with no risk factors at all, only one
patient with non-AIS suffered from shunt infection. In
patients with one or more risk factors, the rate for shunt
infection was 7.14 % in patients with non-AIS and 6.94 %
in patients with AIS. If one disregards treatment the differ-
ence of 1.7% shunt infections in patients without risk fac-
tors and 7.1% in patients with at least one risk factor is not
significant (p = 0.2038, OR = 4.5; 95% CI 0.6 – 34.9).
Analysis of the single factors together with the influence of
treatment, i.e. using AIS catheters or not, on the risk of a
Table 1: Demographic data, classification of hydrocephalus and 
shunt type
AIS n = 86 non-AIS n = 172 P value
Mean age [years] 32.8 42.4 0.0071*1
Sex [female/male] 49/37 95/77 0.89432
Functional 
classification of 
hydrocephalus
0.09712
Obstructive / 17 50
communicating / 68 114
Not-classified 1 8
Shunt type 0.33723
Codman programmable 73 143
Hakim 11 17
Medos for children 1 2
Others 1 10
AIS patients were significantly younger than non-AIS patients.
1t-test. 2Fisher's exact test. 3Pearson. P significant at < 0.05.BMC Infectious Diseases 2007, 7:38 http://www.biomedcentral.com/1471-2334/7/38
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shunt infection, showed that only a former shunt infec-
tion (see Table 2) were significantly related to a higher risk
for suffering from shunt infection. The use of AIS or non-
AIS had no significant advantage. (p = 0.8611; multiple
logistic regression). Also significantly related to a shunt
infection was the number of shunt surgeries. 598 surgical
interventions had been performed, 190 interventions in
the AIS group (2.21 interventions per patient), 408 in the
non-AIS group (2.37 interventions per patient) (Wilcoxon
test, p = 0.3063). There was no shunt infection in the
group of patients on whom only one shunt surgery was
performed. In patients who had undergone at least two
shunt surgeries, we observed 15 out of 166 patients with
shunt infections, i.e. 9% (p = 0.0015; Fisher's exact test).
Comparing the 52 patients with AIS and the 114 patients
without AIS with respect to the incidence of shunt infec-
tions, we obtain 5/52 (9.6 %) and 10/114 (8.8 %), respec-
tively (p = 1.0; Fisher's exact test), see Table 6.
In Table 7, patients who suffered from shunt infection are
presented in detail. Fourteen infections occurred within
the first 6 months after shunt insertion independently of
the type of shunt used (AIS or non-AIS). The most fre-
quent pathogen for shunt infection was S. epidermidis. In
the AIS group one out of five bacteria could not be classi-
fied, furthermore no antibiogram was available. Only in
one patient the S. epidermidis was resistant to clindamy-
cin and rifampicin. In the other three patients S. epider-
midis and S. aureus were sensitive to both antibiotics. In
the non-AIS shunt infection group, only two patients had
an infection with S. aureus or S. epidermidis, which were
sensitive to both antibiotics (clindamycin and
rifampicin).
Patient ID 9 showed a skin ulceration 178 days after shunt
implantation, patient ID 14 showed a galea ulceration
after 148 days.
Patient ID 16. This prematurely born patient had her first
shunt implantation at day 13 postpartum. Three months
later the shunt system was changed due to dysfunction. 20
days later the child suffered from a liquor fistula, another
surgery was done. 6 days later the first liquor infection
with S. epidermidis was seen. The patient was treated with
systemic antibiotics. Three months later another neuro-
surgical procedure was performed. A supratentorial cyst
was opened by endoscopic surgery. Five days later the
child had a second liquor infection with S. epidermidis,
again the infection was treated by antibiotics.
Patient ID 17. This 3.5 year old child, who was born in the
25th week of pregnancy, had her first shunt implantation
after intraventricular hemorrhage. In the age of 3.5 years a
shunt revision was necessary, because the supratentorial
ventricles were collapsed and the fourth ventricle was
enlarged. Three months later a second surgery was neces-
sary because the catheter in the fourth ventricle had to be
replaced. 12 days later the child suffered from shunt infec-
tion, the shunt was removed, liquor was temporarily
drained by an external ventricular drainage. Additionally
she got systemic antibiotic therapy. 18 days later a new
AIS system was implanted. Unfortunately, the child suf-
fered from external shunt infection ten months later, and
the complete system had to be removed again.
In all patients no AIS-correlated complications occurred,
specifically there were no toxic or allergic complications.
No patient presented epileptic problems after antibiotics
impregnated shunt implantation. Only one infection was
cured merely by systemic antibiotics. In all other patients
Table 5: Comparing rate of shuntinfection by risk factors and 
AIS vs non-AIS
Risk factors No shuntinfection Shuntinfection n
No non-AIS 45 (97.83%) 1 (2.17 %) 46
No AIS 14 (100 %) 0 (0 %) 14
Yes non-AIS 117 (92.86 %) 9 (7.14 %) 126
Yes AIS 67 (93.06 %) 5 (6.94 %) 72
n 243 15 258
AIS differs not from non-AIS; p = 0.4660 by Pearson
Table 3: Risk of shuntinfection by age
no shuntinfection shuntinfection
Age [years] 1 – 80 211 (93.78 %) 14 (6.22 %) 225
Age [years] < 1 or > 80 32 (96.97 %) 1 (3.03 %) 33
243 15 258
Table 2: Risk factors for shunt infection independent of the 
treatment (AIS vs non-AIS)
Risk factor Odds Ratios P value
Age (< 1 year and > 80 years) 0.5 (0.06–3.7) 0.7010
Premature birth 2.1 (0.6–7.9) 0.2300
External ventricular drainage 1.9 (0.7–5.5) 0.2732
Former shunt infection 5.0 (1.6–16.0) 0.0124*
Former systemic infection 2.9 (1–8.8) 0.0605
Disturbance of consciousness 2.1 (0.6–7.9) 0.2300
Former Radiation-/Chemotherapy 2.2 (0.6–8.3) 0.2138
Odds ratio (OR) and 95 % confidence interval were calculated on the 
basis of Fisher's exact test, *significant at p < 0.05;
Table 4: Risk of shunt infection by former shuntinfection
No shuntinfection shuntinfection
No former shuntinfection 221 (95.67 %) 10 (4.33 %) 231
Former shuntinfection 22 (81.48 %) 5 (18.52 %) 27
243 15 258BMC Infectious Diseases 2007, 7:38 http://www.biomedcentral.com/1471-2334/7/38
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the complete shunt system was removed, followed by
temporary external liquor drainage and systemic antibi-
otic treatment. There was no failure of infection therapy.
Discussion
Shunt infections result mostly from intra-operative con-
tamination by coagulase-negative staphylococci and other
skin flora [20,21]. After adhesion to the implanted sur-
face, the coagulase-negative staphylococci produce an
extracellular mucoid biofilm, called ‚slime‘, embedding
the bacteria and protecting them from the antibiotics [22-
24]. Based on these findings, effective prophylaxis of
infection begins with the prevention of initial bacterial
adhesion to the shunt material. One way to establish this
is to optimize the operating theatre and the shunt proce-
dures as described by Choux et al. in 1992 [13] and Chok-
sey and Malik in 2004 [11]. This may be possible, if at all,
in hospitals with highly trained specialized neurosur-
geons and nurses. In teaching hospitals with trainees and
in developing countries it will be difficult to achieve these
standards. Therefore, additional efforts for preventing
shunt infections are necessary. One method is to reduce
the risk factors causing infection. Reducing risk factors
causing cerebrospinal fluid shunt infections is a contro-
versial debate. In many reports risk factors like the differ-
ent types of hydrocephalus [25,26], young age of the
patient [27], presence of a previous external drainage or
shunt system are accepted as unsusceptible risk factors.
Susceptible risk factors for shunt infection are the dura-
tion of shunt surgery and the number of people present in
the operating room [13].
In a prospective study 2001 Kulkarni et al. investigated
risk factors causing shunt infections [28]. They found that
only postoperative cerebrospinal fluid leakage, young age
of the patients (premature infants), and perforated sur-
geon's gloves were significant risk factors for shunt infec-
tions. No common consensus exists at all for risk factors
responsible for shunt infection.
In the presented data a significant correlation between
developing shunt infection existed only for the number of
surgeries and former shunt infection. The presented data
show similar infection rates in the compared groups (AIS
versus non-AIS). In the AIS group, in which 83.7 % of the
patients had at least one risk factor, 5.81 % suffered from
shunt infection. In the non-AIS group, in which 73.3 %
had risk factors, 5.81 % had a shunt infection. Although
some reader may suspect that some bias in the two groups
may be possible, statistical analysis demonstrated no sig-
Table 7: Shunt infections, clinical data, AIS vs non-AIS, pathogens and antibiograms.
ID Age [year] Sex No. of risk factors Time to infection1 [days] AIS2 Organism Rifampicin Clindamycin
15 54.3 f 2 6 0 S. epidermidis s r
10 50.2 m 1 12 0 Citrobacter koseri r not tested
8 53.5 m 2 15 0 S. epidermidis s r
1 61.3 f 4 15 0 S. epidermidis r r
11 72.1 m 2 22 0 S. epidermidis s s
5 25.4 m 0 28 0 S. epidermidis r r
3 65.4 f 2 36 0 S. epidermidis s r
14 45.0 f 2 148 0 S. aureus s s
6 4.0 f 3 170 0 S. epidermidis s s
7 77.5 f 1 375 0 Proprioni bacterium acnes not tested s
4 74.3 f 3 4 1 S. epidermidis r r
12 66.7 f 1 13 1 gram positive coccus*1 unknown unknown
16 0.3 f 4 26/5 1 S. epidermidis s s
9 53.4 f 4 178 1 S. aureus*2 ss
17 3.5 f 2 106/294 1 S. epidermidis s s
1 Time to infection between shunt implantation and shunt explantation.
2 AIS: Antibiotic impregnated shunt: 0 = no, 1 = yes
*1 gram positive coccus, no specific differentiation possible; *2 Methicillin resistent
Table 6: Comparing rate of shuntinfection by the number of 
shunt surgery and AIS vs non-AIS
No. of shunt 
surgery
No shuntinfection Shuntinfection N
1 non-AIS 58 (100 %) 0 (0 %) 58
1 AIS 34 (100 %) 0 (0 %) 34
2 or more non-AIS 104 (91.23 %) 10 (8.77 %) 114
2 or more AIS 47 (90.38 %) 5 (9.62 %) 52
n 243 15 258
AIS does not differ from non-AIS (p = 0.8611) but No. of shunt 
surgery >1 differs significantly from No. = 1 (p = 0.0002); (multiple 
logistic regression)BMC Infectious Diseases 2007, 7:38 http://www.biomedcentral.com/1471-2334/7/38
Page 6 of 8
(page number not for citation purposes)
nificant differences in both groups with only one excep-
tion, i.e. younger mean age of the AIS group.
In contrast to the risk factors, high consensus exists in the
literature regarding the pathogens causing shunt infec-
tions. Coagulase-negative staphylococci, mostly derived
from the patient's skin flora during surgery, colonize the
inner surfaces of the shunt tubing [20,29,30]. Staphyloco-
cci (S. epidermidis and aureus) are the bacteria that cause
shunt infections most frequently [31]. Gram negative bac-
teria were found less frequently. The presented data are in
accordance with these findings. The most frequent bacte-
ria noted was S. epidermidis. Remarkably, three out of six
infections in the AIS group were caused by S. epidermidis
or aureus, which were sensitive to clindamycin and
rifampicin. It is assumed that the contamination of the
shunts happened after shunt implantation. In only one
case, the causing bacteria were resistant to both antibiot-
ics.
More than 90 % of infections are diagnosed within the
first 12 months from surgery [32]. In our study one
patient had a late shunt infection, caused by propionibac-
terium acnes (375 days). Schiff et al. reported a rate of 1
% late shunt infections, defined as 6 months after surgery,
the most common organisms were propionibacterium
species and S. epidermidis species [33]. There are several
causes for the failure of infection protection. According to
Bayston et al., it takes 48 to 58 h to destroy 100 % of the
adhered bacteria, the protective activity of the impreg-
nated shunt has a duration of more than 50 days [34].
Recently Pattavilakom et al. reported about antimicrobial
activity for a period of up to 127 days after ex vivo explan-
tation of antibiotic impregnated cerebrospinal fluid cath-
eters [35].
A possible explanation for the failure of infection proph-
ylaxis in the AIS group could be the fact that the ventricu-
lar catheter and the distal shunt catheter are antibiotic-
impregnated, whereas the valve and the Rickham reservoir
are not.
Other possible explanations could be further invasive
interventions such as neurosurgical procedures or skin
ulcerations. In the presented data patient ID 9 showed
ulceration of the skin. The ulceration in this severely disa-
bled patient had its manifestation 178 days after implan-
tation of the shunt. This explains the infection time. The
shunt infection was obviously caused by the ulceration
which cannot be prevented by AIS. In the non-AIS group,
patient ID 14 was in a comparable situation. This patient
had an ulceration of her galea. The shunt system had to be
removed after 148 days. As there were late infections
based on ulcerations of the galea in both groups, we
included both patients in the statistical analysis, otherwise
the total infection rate would be incorrectly too low.
Comparing AIS with non-AIS, the presented data could
not demonstrate a significant reduction of shunt infection
by AIS. Remarkably we found three out of five infections
in the AIS group which were caused by skin ulcerations or
neurosurgerical procedures highly susceptible for contam-
ination after initial shunt implantation. Furthermore, the
infection rate in the non-AIS group was obviously smaller
than reported in the literature. Sciubba et al. [36] retro-
spectively investigated 211 pediatric patients with 353
shunt placement procedures over a 3-year period. In the
first 18 months, 208 shunts were placed with non-impreg-
nated catheters. 12 % of these patients had shunt infec-
tions compared to only two patients (1.4 %) out of 141 in
whom AIS had been inserted in the second 18 months.
The authors could demonstrate a significant decrease in
the infection rate in the AIS group by changing their man-
agement. Aryan [2] investigated 32 Bactiseal shunt
implantations in 31 children aged from 6 months to 17
years and compared them to patients treated with non-
impregnated shunts. In the AIS group 12.5 % early and
18.8 % late complications occurred compared to 23.4 and
34.8 % in the non-AIS group.
Prospective randomized blind studies are highly appreci-
ated. To show a statistically significant decrease from 6 to
3 % shunt infections, a prospective study with 1628
patients would be necessary presuming a significance
level of 5 % using by Fisher's exact test. To the best knowl-
edge of the authors only prospective studies with a fewer
number of patients exist. Govender and coworkers [37]
showed a significantly decreased infection rate from 16 %
in the control group to 6 % in the AIS group in a prospec-
tive randomized blind study including 110 patients. Our
infection rate in the AIS group is comparable to their
results. In contrast to Govender et al. and Sciubba et al.
[36], the risk of shunt infection in non-AIS patients in this
study was very low (5.81 %). The study of Govender et al.
was performed in a single center in South Africa, where
diverse problems such as a high infection rate with HIV
and malnutrition compared to highly industrialized
countries exist. This might explain the high infection rate
in their non-AIS group.
The infection rate in our investigation did not achieve the
excellent results reported by Choux et al. and Chouksey et
al. [11,13]. In the cited reports, shunt operations were per-
formed by one very experienced surgeon with the aim to
reduce shunt infections. In the actual investigation surgery
was done by various surgeons, including residents in neu-
rosurgery with an infection rate of 6 % in all patients. This
is probably general practice in most neurosurgical training
centers at university hospitals.BMC Infectious Diseases 2007, 7:38 http://www.biomedcentral.com/1471-2334/7/38
Page 7 of 8
(page number not for citation purposes)
AIS did not reduce the infection rate in the presented
study. Nevertheless it must be noted that in the AIS group
three patients suffered from shunt infections caused by
skin ulceration or neurosurgical procedures with exposi-
tion of the cerebrospinal liquor after shunt implantation.
AIS was not developed to prevent infection in such cases,
therefore an advantage of AIS is not excluded.
Conclusion
Using AIS or not it is still important to obey consequently
the surgical principles of aseptic and atraumatical prepa-
ration. Based on the presented data and the small number
of reported studies a prospective randomized multicenter
study is required.
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